phone icon  Toll Free : +1-800-792-5285 | (UK) : + 44-845-528-1300
Allied Market Research

0
Shopping Cart is Empty..
$ 0
CART  yellow arrow
 

Intraoperative Neuromonitoring Market Overview:

Global intraoperative neuromonitoring market size was valued at $3,036 million in 2015, and is expected to reach $4,900 million by 2022, growing at a CAGR of 7.0% during the forecast period. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique that reduces the risk of neurological deficits during and after surgeries involving nervous system. An IONM system uses recordings of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical procedure. The use of neuromonitoring is important during surgeries as it helps in detection of injuries before they become so severe that they cause post-operative complications in the patients. Therefore, IONM reduces risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other normal body functions.

Ageing population, increase in prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries drive the market. However, the market growth is limited due to dearth of skilled professionals and low awareness of IONM in the developing nations. Conversely, increase in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.

Intraoperative Neuromonitoring Market Segmentation

Segment Review

Intraoperative neuromonitoring market analysis shows that IONM has its applications in various surgical procedures such as spine surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries where there is involvement of nervous system. IONM has become an important tool to minimize post-operative injuries. Wide applications of IONM along with a global rise in the number of surgeries majorly drives the IONM market. According to WHO, an estimated 266.2 to 359.5 million surgeries were performed globally in 2012. This represented an increase of 38% over the previous eight years. The estimates also demonstrated that largest increase in the number of surgeries was observed in very-low- and low-expenditure Member States of the UNO. This is anticipate to lead to growth of intraoperative neuromonitoring industry as the target consumers are not limited to any specific age group, gender, or disease type.

Intraoperative Neuromonitoring Market, By Application, 2015 (%)

Shift towards Outsourced Monitoring

Outsourced IONM monitoring is growing at a fast pace due to its benefits over insourced monitoring. Now-a-days, hospitals generally do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set and they cannot offer the training standardization that is required to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ASCs. In addition, IONM professionals also prefer to work for an outsourcing provider as they can work simultaneously for more than one hospital by working in an outsourcing IONM provider. Thus, the outsourcing intraoperative neuromonitoring market is expected to witness a high growth throughout the forecast period. Moreover, an outsourced provider can purchase one device and work for many hospitals in the same local area.

Saudi Arabia Intraoperative Neuromonitoring Market, 2014-2022 ($Million)

Top Investment Pockets

ENT surgery and orthopedic surgery are attractive areas of investment in IONM market as these surgeries pose a potential risk to the neural structures and require a technique which protects nerves (and other related structures) during the procedure. Thus, orthopedic and ENT surgeries are prominent areas for investment in IONM market.

Top Investment Pockets in Intraoperative Neuromonitoring Market

Clinical Trials

As IONM is a new field, there are few clinical trials in IONM market. Europe accounted for the maximum number of trials (12) in the market followed by North America (11). Asia-Pacific and LAMEA accounted for a small share (one clinical trial in each region) in the intraoperative neuromonitoring market.

Clinical Trials in Intraoperative Neuromonitoring Market (%)

The list of key players profiled in this report include Medtronic plc, NuVasive, Inc., Computational Diagnostics, Inc., SpecialtyCare, Natus Medical Incorporated., IntraNerve, LLC, inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation and Moberg Research, Inc. Key players in the value chain include Argos Neuromonitoring LP, Medsurant Holdings, LLC, NeuroMonitoring Technologies, Inc. and Cadwell Industries, Inc.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps understand various types of devices used for treatment and monitoring of cardiac patients.
  • Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.

Intraoperative Neuromonitoring Market Key Segments

By Products & Services

  • Systems
  • Accessories
  • Services

By Source Type

  • Insourced Monitoring
  • Outsourced Monitoring

By Application

  • Spinal Surgery
  • Neurosurgery
  • Vascular Surgery
  • ENT Surgery
  • Orthopedic Surgery
  • Other Surgeries

By Modality

  • Motor Evoked Potentials (MEPs)
  • Somatosensory Evoked Potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem Auditory Evoked Potentials (BAEPs)
  • Visual Evoked Potentials (VEPs)

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Enquiry About Report

Let us know more about your research need and we will customize an offer exclusively for you!

Please input above shown text into input box
or click refresh

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies

3.3. PLAYER POSITIONING, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Applications of IONM in different surgeries
3.4.1.4. Risk management through IONM during complex surgeries

3.4.2. Restraints

3.4.2.1. Low awareness of IONM in developing nations
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Increasing medical tourism
3.4.3.2. Growth opportunities in the emerging economies

3.4.4. Impact analysis

3.5. CLINICAL TRIALS
3.6. REIMBURSEMENT SCENARIO IN U.S.

Chapter: 4 INTRAOPERATIVE NEUROMONITORING MARKET BY PRODUCTS & SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SYSTEMS

4.2.1. Market size and forecast

4.3. ACCESSORIES

4.3.1. Market size and forecast

4.4. SERVICES

4.4.1. Market size and forecast

Chapter: 5 INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. INSOURCED MONITORING

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.3. OUTSOURCED MONITORING

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

Chapter: 6 INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. SOMATOSENSORY EVOKED POTENTIALS (SSEPS)

6.2.1. Market size and forecast

6.3. ELECTROMYOGRAPHY (EMG)

6.3.1. Market size and forecast

6.4. ELECTROENCEPHALOGRAPHY (EEG)

6.4.1. Market size and forecast

6.5. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS)

6.5.1. Market size and forecast

6.6. MOTOR EVOKED POTENTIALS (MEPS)

6.6.1. Market size and forecast

6.7. VISUAL EVOKED POTENTIALS (VEPS)

6.7.1. Market size and forecast

Chapter: 7 INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. SPINAL SURGERY

7.2.1. Market size and forecast

7.3. ENT SURGERY

7.3.1. Market size and forecast

7.4. NEUROSURGERY

7.4.1. Market size and forecast

7.5. VASCULAR SURGERY

7.5.1. Market size and forecast

7.6. ORTHOPEDIC SURGERY

7.6.1. Market size and forecast

7.7. OTHER SURGERIES

7.7.1. Market size and forecast

Chapter: 8 INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. HOSPITALS

8.2.1. Market size and forecast

8.3. AMBULATORY SURGICAL CENTERS (ASCS)

8.3.1. Market size and forecast

Chapter: 9 INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S.
9.2.5. Canada
9.2.6. Mexico

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany
9.3.5. France
9.3.6. UK
9.3.7. Italy
9.3.8. Spain
9.3.9. Rest of Europe

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast
9.4.4. Japan
9.4.5. China
9.4.6. India
9.4.7. South Korea
9.4.8. Australia
9.4.9. Rest of Asia-Pacific

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Brazil
9.5.5. South Africa
9.5.6. Saudi Arabia
9.5.7. Rest of LAMEA

Chapter: 10 COMPANY PROFILES

10.1. ACCURATE MONITORING, LLC

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Key strategic moves & developments

10.2. COMPUTATIONAL DIAGNOSTICS, INC.

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Key strategic moves & developments

10.3. INOMED MEDIZINTECHNIK GMBH

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Key strategic moves & developments

10.4. INTRANERVE, LLC

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Key strategic moves & developments

10.5. MEDTRONIC PLC

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Business performance
10.5.5. Key strategic moves & developments

10.6. MOBERG RESEARCH, INC

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Key strategic moves & developments

10.7. NATUS MEDICAL INCORPORATED.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Business performance
10.7.5. Key strategic moves & developments

10.8. NIHON KOHDEN CORPORATION

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves & developments

10.9. NUVASIVE, INC.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves & developments

10.10. SPECIALTYCARE

10.10.1. Company overview
10.10.2. Company snapshot
10.10.4. Key strategic moves & developments

LIST OF TABLES

TABLE 1. CLINICAL TRIALS IN IONM MARKET
TABLE 2. COMPLETED CLINICAL TRIALS IN INTRAOPERATIVE NEUROMONITORING MARKET
TABLE 3. BASE (PRIMARY) CODES FOR IONM MODALITIES
TABLE 4. HOSPITAL INPATIENT CODES
TABLE 5. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
TABLE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
TABLE 11. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 17. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 18. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
TABLE 19. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 20. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 21. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
TABLE 23. HOSPITALS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 24. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
TABLE 26. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 27. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 28. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 29. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 30. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 31. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 32. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 33. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 34. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 35. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 36. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
TABLE 37. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 38. ACCURATE MONITORING: COMPANY SNAPSHOT
TABLE 39. COMPUTATIONAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 40. INOMED: COMPANY SNAPSHOT
TABLE 41. INOMED: OPERATING SEGMENTS
TABLE 42. INTRANERVE: COMPANY SNAPSHOT
TABLE 44. MEDTRONIC: COMPANY SNAPSHOT
TABLE 45. MEDTRONIC: OPERATING SEGMENTS
TABLE 46. MOBERG RESEARCH: COMPANY SNAPSHOT
TABLE 47. MOBERG RESEARCH: OPERATING SEGMENTS
TABLE 48. NATUS MEDICAL: COMPANY SNAPSHOT
TABLE 49. NATUS MEDICAL: OPERATING SEGMENTS
TABLE 50. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 51. NIHON KOHDEN: OPERATING SEGMENTS
TABLE 52. NUVASIVE: COMPANY SNAPSHOT
TABLE 53. NUVASIVE: OPERATING SEGMENTS
TABLE 54. SPECIALTYCARE: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. PLAYER POSITIONING, 2015
FIGURE 9. IMPACT ANALYSIS: INTRAOPERATIVE NEUROMONITORING MARKET
FIGURE 10. GLOBAL IONM MARKET, BY PRODUCTS & SERVICES ($MILLION), 2014-2022
FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING SYSTEMS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING ACCESSORIES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING SERVICES MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE ($MILLION), 2014-2022
FIGURE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING SOURCE TYPE MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 16. GLOBAL INSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 17. GLOBAL OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY ($MILLION), 2014-2022
FIGURE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR SSEPS ($MILLION), 2014-2022
FIGURE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EMG ($MILLION), 2014-2022
FIGURE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR EEG ($MILLION), 2014-2022
FIGURE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR BAEPS ($MILLION), 2014-2022
FIGURE 23. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR MEPS ($MILLION), 2014-2022
FIGURE 24. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET FOR VEPS ($MILLION), 2014-2022
FIGURE 25. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION ($MILLION), 2014-2022
FIGURE 26. GLOBAL INTRAOPERATIVE NEUROMONITORING APPLICATIONS MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 27. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR SPINAL SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 28. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ENT SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 29. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR NEUROSURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 30. GLOBAL INTRAOPRATIVE NEUROMONITORING FOR VASCULAR SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 31. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR ORTHOPEDIC SURGERY, BY REGION ($MILLION), 2014-2022
FIGURE 32. GLOBAL INTRAOPRATIVE NEUROMONITORING MARKET FOR OTHER SURGERIES, BY REGION ($MILLION), 2014-2022
FIGURE 33. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 34. HOSPITALS & CLINICS INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 35. AMBULATORY SURGICAL CENTERS (ASCS) INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 36. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION ($MILLION), 2014-2022
FIGURE 37. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 38. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 39. NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 40. U.S. IONM MARKET ($MILLION), 2014-2022
FIGURE 41. CANADA IONM MARKET ($MILLION), 2014-2022
FIGURE 42. MEXICO IONM MARKET ($MILLION), 2014-2022
FIGURE 43. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 44. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 45. EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 46. GERMANY IONM MARKET ($MILLION), 2014-2022
FIGURE 47. FRANCE IONM MARKET ($MILLION), 2014-2022
FIGURE 48. UK IONM MARKET ($MILLION), 2014-2022
FIGURE 49. ITALY IONM MARKET ($MILLION), 2014-2022
FIGURE 50. SPAIN IONM MARKET ($MILLION), 2014-2022
FIGURE 51. REST OF EUROPE IONM MARKET ($MILLION), 2014-2022
FIGURE 52. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 53. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 54. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 55. JAPAN IONM MARKET ($MILLION), 2014-2022
FIGURE 56. CHINA IONM MARKET ($MILLION), 2014-2022
FIGURE 57. INDIA IONM MARKET ($MILLION), 2014-2022
FIGURE 58. SOUTH KOREA IONM MARKET ($MILLION), 2014-2022
FIGURE 59. AUSTRALIA IONM MARKET ($MILLION), 2014-2022
FIGURE 60. REST OF ASIA-PACIFIC IONM MARKET ($MILLION), 2014-2022
FIGURE 61. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY ($MILLION), 2014-2022
FIGURE 62. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS & SERVICES, 2014-2022 ($MILLION)
FIGURE 63. LAMEA INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 64. BRAZIL IONM MARKET ($MILLION), 2014-2022
FIGURE 65. SOUTH AFRICA IONM MARKET ($MILLION), 2014-2022
FIGURE 66. SAUDI ARABIA IONM MARKET ($MILLION), 2014-2022
FIGURE 67. REST OF LAMEA IONM MARKET ($MILLION), 2014-2022
FIGURE 68. MEDTRONIC: NET SALES, 2013-2015 ($MILLION)
FIGURE 69. MEDTRONIC: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 70. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 71. NATUS MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIGURE 72. NATUS MEDICAL: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 73. NATUS MEDICAL: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 74. NIHON KOHDEN: NET SALES, 2013-2015 ($MILLION)
FIGURE 75. NIHON KOHDEN: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 76. NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)
FIGURE 77. NUVASIVE: NET SALES, 2013-2015 ($MILLION)
FIGURE 78. NUVASIVE: NET SALES, BY SEGMENT, 2015 ($MILLION)
FIGURE 79. NUVASIVE: NET SALES, BY GEOGRAPHY, 2015 ($MILLION)

There has been a remarkable increase in the use of IONM devices by hospitals and ambulatory surgical centers during complex surgeries. Moreover, the market is moving towards outsourced monitoring to provide advanced treatment options for patients suffering from chronic diseases. North America is projected to generate the highest revenue, whereas Asia-Pacific is expected to offer lucrative opportunities to the key players in this market.

Ageing population, increase in prevalence of chronic disorders, application of IONM in different surgeries, and risk management through IONM during complex surgeries drive the market. However, unawareness of IONM in developing nations and dearth of skilled professionals hamper the growth. Conversely, increase in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period. Majority of the manufacturers and distributors focus to expand their presence in emerging economies.

North America is expected to dominate the global IONM market during the forecast period due to high adoption of IONM services, better reimbursement policies, awareness among physicians and patients about IONM, and developed infrastructure.

License Type
Data Pack
Single User PDF
Five User Online/PDF
Enterprise Online/PDF
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Restricted to one authorized user

Limited to 5 authorized users


Unlimited within company / enterprise
Printing
One Print only

One Print only
Up to Five Copies
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
Speak with analyst
connect
Did you miss anything?
To add more
request

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Featured Readings



Apr 2017

Patient Monitoring Devices Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022



Apr 2017

Medical Electrodes Market- Global Opportunities and Forecasts, 2014 - 2022

Further Readings



Nov 2017

World Intraoperative Imaging Market- Opportunities and Forecasts, 2017-2023



Nov 2017

North American Intraoperative Imaging Market- Opportunities and Forecasts, 2017-2023



Nov 2017

Esmolol Hydrochloride Market- Global Opportunities and Industry Forecasts, 2017-2023



Nov 2017

Global Integrated Operating Room Market- Opportunity Analysis and Industry Forecast, 2017-2023

 

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

About
US
Find
HELP
Consulting &
CUSTOM STUDIES
Our
PRODUCTS
Our
SERVICES
Press
MEDIA
STAY WITH US

fb blogger linkedin Gplus twitter Youtube Rss

WE ACCEPT


weAccept